Literature DB >> 8070348

Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes.

J Dai1, C D Scott, R C Baxter.   

Abstract

The acid-labile subunit (ALS) is a glycoprotein that forms a ternary complex in serum with insulin-like growth factors and insulin-like growth factor-binding protein-3. This study investigates the regulation of ALS production, measured by RIA, and messenger RNA (mRNA) content, measured by Northern analysis, in primary rat hepatocyte monolayer cultures. Hepatocytes produced ALS at a linear rate over 48 h. Exposure to human GH (30 ng/ml) caused a maximum 2.2-fold stimulation of ALS production compared to that in control cultures, giving a rate of 200 ng/10(6) cells.48 h. ALS mRNA appeared as a predominant 2-kilobase band and increased 4-fold by administration of 30 ng/ml GH. Both dexamethasone and epidermal growth factor (EGF) inhibited ALS production, with maximal effects at 100 nM dexamethasone and 50 ng/ml EGF (both approximately 50% inhibition). ALS mRNA levels measured 24 or 48 h after dexamethasone addition were decreased 75-80% compared to the control value. A similar decrease in ALS mRNA was observed 24 h after EGF addition, but a second addition of EGF at 24 h was required to maintain this decrease for 48 h. This study demonstrates that rat hepatocytes secrete immunoreactive ALS under GH regulation, and that EGF and corticosteroid inhibit ALS production and mRNA levels. The quantitative discrepancies between ALS production rates and mRNA levels suggest that posttranscriptional events may have a role in ALS regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070348     DOI: 10.1210/endo.135.3.8070348

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Dexamethasone does not increase IGF-I and IGFBP-3 levels in man in the absence of endogenous GH.

Authors:  F E Finamor; A M Lengyel
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

2.  Organization and chromosomal localization of the gene encoding the mouse acid labile subunit of the insulin-like growth factor binding complex.

Authors:  Y R Boisclair; D Seto; S Hsieh; K R Hurst; G T Ooi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

3.  Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation.

Authors:  Masanobu Fujimoto; Melissa Andrew; Lihong Liao; Dongsheng Zhang; Gozde Yildirim; Patrick Sluss; Bhanu Kalra; Ajay Kumar; Shoshana Yakar; Vivian Hwa; Andrew Dauber
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

4.  Evaluation of insulin-like growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expression.

Authors:  Brenna M Flannery; Chidozie J Amuzie; James J Pestka
Journal:  Toxicology       Date:  2013-01-05       Impact factor: 4.221

5.  Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone.

Authors:  Vernon W Dolinsky; Donna N Douglas; Richard Lehner; Dennis E Vance
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

6.  Effect of insulin treatment on circulating insulin-like growth factor I and IGF-binding proteins in cats with diabetes mellitus.

Authors:  Emma M Strage; Mårten Sundberg; Bodil S Holst; Mikael Andersson Franko; Margareta Ramström; Tove Fall; Moira Lewitt
Journal:  J Vet Intern Med       Date:  2018-08-16       Impact factor: 3.333

7.  The mir-465 family is upregulated with age and attenuates growth hormone signaling in mouse liver.

Authors:  Amy E Elias; Bianca Kun; Ian M C Sabula; Gail Golomb-Mello; Andrea Cespedes Zablah; Jill A Kreiling
Journal:  Aging Cell       Date:  2019-01-13       Impact factor: 9.304

8.  Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study.

Authors:  S I Helle; J Geisler; J P Poulsen; K Hestdal; K Meadows; W Collins; K M Tveit; J M Holly; P E Lønning
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

Review 9.  Post-Receptor Inhibitors of the GHR-JAK2-STAT Pathway in the Growth Hormone Signal Transduction.

Authors:  Maciej Wójcik; Agata Krawczyńska; Hanna Antushevich; Andrzej Przemysław Herman
Journal:  Int J Mol Sci       Date:  2018-06-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.